R&D Partner Content 2nd ADC Payload Summit Diversifying ADC Payloads as Warheads for Overcoming Tumor Resistance, With Optimized Efficacy, Potency, Mechanisms & Differentiated IP
Oncology Antibody drug conjugates – The time is now The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs ca
Partner Content Partner Content BioPharmaLogic, Antikor Biopharma and UCL Host 2 Must Attend... ADC Summit
Partner Content Partner Content Exclusive Speaker Interview from Seattle Genetics for SMi’s ... Interview from Seattle Genetics
Partner Content Partner Content Hear the Keynote Addresses from MedImmune and Spirogen this ... Antibodies & Antibody Drug Conjugates
News UK partners with Eli Lilly on obesity plan The UK has teamed up with Eli Lilly on initiatives, backed with £85 million in funding, to expand access to treatment for obesity.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.